01
Dec
2009
Posted in I - Series C, Q - 4Q09, R - NORTH EAST, X - Device (Diagnostic), X - MRSA, XX - PA
Molecular Detection (Wayne, PA) a development-stage molecular diagnostics company focused on reat-time PCR of MRSA detection, closed a $3.3M Series C financing. Participants include MentorTech Ventures, Ben Franklin Technology Partners, Robin Hood Ventures and the Mid-Atlantic Angel Group.